Fig. 2From: Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) knowDifferent possible models of HPD development. a HPD as a monofactorial process. b HPD as a multifactorial process. c HPD as a cascade of simultaneous eventsBack to article page